Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NeoFuse in multi-level anterior cervical discectomy and fusion
NCT01106417Phase 2Completed
- Sponsor
- Mesoblast Ltd
- Start
- Jun 2010
- Primary completion
- May 2012
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of rexlemestrocel-l in cervical degenerative disc disease (CDDD), sponsored by Mesoblast Ltd. Started Jun 2010; status: completed.
02
Drugs
rexlemestrocel-l
03
Conditions
cervical degenerative disc disease (CDDD)
Beyond the preview
Go deeper on NCT01106417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01106417.